Health Canada has expanded the approved use of Ozempic (semaglutide injection) to help reduce the risk of serious cardiovascular complications in adults living with type 2 diabetes.
This means this GLP-1 medication is now approved not only for blood sugar control, but also for reducing the risk of heart attack, stroke, and cardiovascular death in people with type 2 diabetes who have cardiovascular disease or chronic kidney disease.
The decision reflects growing medical evidence that certain diabetes medications can help protect both blood sugar control and heart health.
Why Cardiovascular Risk Is Important in Diabetes
Cardiovascular disease is the leading cause of illness and death in people with type 2 diabetes.
Research shows that people with diabetes have significantly higher risks of:
- Heart attack
- Stroke
- Heart failure
- Kidney disease
In Canada, diabetes contributes to:
- About 40% of heart attacks
- About 30% of strokes
Because of this, modern diabetes management focuses on reducing cardiovascular risk in addition to controlling blood glucose levels.
What the New Ozempic Approval Means
Health Canada now approves Ozempic to be used:
- Alongside diet and exercise
- With standard diabetes care
- To reduce major adverse cardiovascular events (MACE)
Major adverse cardiovascular events include:
- Cardiovascular death
- Non-fatal heart attack
- Non-fatal stroke
This expanded indication helps physicians treat both diabetes and cardiovascular risk at the same time.
Oral Semaglutide Also Approved for Heart Protection
The oral form of semaglutide, Rybelsus, also recently received approval to reduce the risk of major cardiovascular events in adults with type 2 diabetes who have cardiovascular disease or are considered at high cardiovascular risk.
Previously, Rybelsus was approved only to improve blood sugar control.
Clinical Trials Supporting the Cardiovascular Benefit
The cardiovascular benefits of semaglutide were demonstrated in several major international clinical trials, including:
- SUSTAIN 6 Trial
- PIONEER 6 Trial
- FLOW Trial
- SOUL Trial
A pooled analysis of nearly 9,800 patients showed that semaglutide therapy significantly reduced the risk of major cardiovascular events compared with placebo.
Researchers observed approximately an 18% reduction in heart attack, stroke, or cardiovascular death in patients receiving semaglutide along with standard diabetes treatment.
How Ozempic Works
Ozempic belongs to a class of medications called GLP-1 receptor agonists.
These medications work by:
- Increasing insulin release when blood sugar is high
- Reducing glucagon production
- Slowing stomach emptying
- Helping reduce appetite and support weight management
Beyond blood sugar control, GLP-1 medications have been shown to provide important cardiovascular and kidney benefits in people with diabetes.
The Role of Pharmacists in Diabetes Medication Management
Medications like Ozempic require proper counselling and monitoring to ensure safe and effective use.
Pharmacists play a key role in helping patients understand:
- How semaglutide works
- How to properly administer injections
- Possible side effects such as nausea or gastrointestinal symptoms
- Interactions with other diabetes medications
- Lifestyle strategies to improve cardiovascular health
At Centrum Pharmacy, pharmacists work closely with patients and their healthcare providers to ensure diabetes medications are used safely and effectively.
Frequently Asked Questions
Is Ozempic only for blood sugar control?
No. Ozempic was originally approved to improve blood sugar control, but Health Canada has now expanded its use to also reduce cardiovascular risk in certain patients with type 2 diabetes.
Who may benefit from Ozempic’s cardiovascular protection?
Patients with:
- Type 2 diabetes
- Established cardiovascular disease
- Chronic kidney disease
- Or high cardiovascular risk
should speak with their healthcare provider to determine whether semaglutide therapy may be appropriate.
Can pharmacists help with Ozempic counselling?
Yes. Pharmacists are trained to provide detailed counselling on diabetes medications, including how to use injectable medications safely and manage potential side effects.
Speak With a Pharmacist
If you have type 2 diabetes and questions about medications like Ozempic or Rybelsus, the pharmacists at Centrum Pharmacy are available to help.A pharmacist can review your medications, answer questions, and help ensure your treatment plan supports both blood sugar control and cardiovascular health.
Stay Connected with Centrum Pharmacy!
If you found this article helpful, don’t forget to like, share, and Follow to stay up to date on our latest health tips, pharmacy updates, and wellness advice.
Come for the Convenience, Stay for the Service.
Caring for Your Family Since 1999
Disclaimer: The medical information on this site is provided as an information resource only and is not to be used or relied on for any diagnostic or treatment purposes. This information does not substitute for professional diagnosis and treatment. Please do not initiate, modify, or discontinue any treatment, medication, or supplement solely based on this information. Always seek the advice of your healthcare provider first. Full Disclaimer.
